Physician profile
Todd B Haddon
NPI 1598751026
$93,792.27
in general payments reported to CMS, 2019-2025
33 companies · $1,155 in 2025
The $1,155 reported for 2025 was more than what 83% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $24K · 2021: $781 · 2022: $6,016 · 2023: $32K · 2024: $1,305 · 2025: $1,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $29K · Food and Beverage: $3,028 · Travel and Lodging: $2,394 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,615.00 |
| Food and Beverage | $3,027.64 |
| Travel and Lodging | $2,393.58 |
| Education | $128.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $50,934.02 | 2019-2025 | Inbone, Infinity, Prophecy |
| Paragon 28, INC. | $37,715.42 | 2019-2024 | Portfolio, Paratrooper, Hammertube |
| Wright Medical Technology, INC. | $1,974.30 | 2019 | |
| Tenex Health INC. | $500.00 | 2020 | |
| Abbott Laboratories | $257.32 | 2020-2025 | Proclaim, Esprit |
| Bioventus LLC | $223.36 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $217.26 | 2019-2024 | Smart Tsf, Evos, Stravix Pl |
| Averitas Pharma INC. | $195.67 | 2024-2025 | Qutenza |
| Alafair Biosciences, INC. | $183.14 | 2025 | Versawrap |
| Orthofix Medical, INC. | $159.99 | 2019-2025 | Physio-Stim, Accelstim |
| Penumbra, INC. | $157.10 | 2022 | |
| Linvatec Corporation | $147.40 | 2024 | Biobrace 23mm |
| Medshape, INC. | $143.54 | 2025 | |
| Fusion Orthopedics USA, LLC | $142.86 | 2025 | |
| Biowound Solutions, INC. | $131.78 | 2025 | Bio-Connekt |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $131.47 | 2022-2024 | |
| Musculoskeletal Transplant Foundation INC. | $127.77 | 2021 | |
| Zimmer Biomet Holdings, INC. | $104.70 | 2024 | |
| Forthright Medical - Az, LLC | $44.56 | 2024 | |
| Mimedx Group, INC. | $43.58 | 2024 | |
| Impactortho, INC. | $40.67 | 2023-2024 | |
| Baxter Healthcare | $33.20 | 2025 | |
| Integra Lifesciences Corporation | $28.59 | 2019 | |
| Kerecis Limited | $24.96 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Amgen INC. | $21.18 | 2025 | Krystexxa |
| Nevro Corp. | $17.79 | 2024 | Senza |
| Lifenet Health | $17.66 | 2025 | Theragenesis Wound Matrix |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.25 | 2019 | |
| Misonix INC | $13.13 | 2020 | |
| Medtronic USA, INC. | $13.04 | 2019 | |
| Kci USA, INC. | $11.96 | 2022 | |
| Terumo Bct, INC. | $11.95 | 2019-2021 | |
| Next Science LLC | $9.65 | 2023 | Surgx, Blastx, Xperience |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Haddon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.